Iron levels found in hemochromatosis patients inhibit -thrombin-induced platelet aggregation

Platelets

Volumn 23, Issue 8, 2012, Pages 611-616

  Lynch, Stephen ^a   Soslau, Gerald ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

thrombin; Hemochromatosis; Iron overload; Platelets

Indexed keywords

GAMMA THROMBIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN;

ARTICLE; CONTROLLED STUDY; HEMOCHROMATOSIS; HUMAN; HYDROLYSIS; IRON BLOOD LEVEL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; CHROMOGENIC COMPOUNDS; FEMALE; HEMOCHROMATOSIS; HUMANS; IRON; MALE; PEPTIDES; PLATELET AGGREGATION; PROTEIN BINDING; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; THROMBIN; UP-REGULATION;

EID: 84868613539     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.634933     Document Type: Article

References (24)

1. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guidelines by the American Association for the study of liver diseases. Hepatology 2011;54:328-343, doi: 10.1002/hep.24330 [Epub ahead of print].
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo Jr R, Ellis MC, Fullan A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
3. Pietrangelo A. Non-HFE hemochromatosis. Semin Liver Dis 2005;25:450-460.
4. Carroll GJ, Breidahl WH, Bulsara MK, Olynyk JK. Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 2011;63:286-294.
5. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-1995.
6. Corradini E, Ferrara F, Pietrangelo A. Iron and the liver. Pediatr Endocrinol Rev 2004;2(Suppl. 2):245-248.
7. Lefton HB, Rosa A, Cohen M. Diagnosis and epidemiology of cirrhosis. Med Clin North Am 2009;93:787-799.
8. Huang J, Jones D, Luo B, Sanderson M, Soto J, Abel ED, Cooksey RC, McClain DA. Iron overload and diabetes risk: A shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes 2011;60:80-87.
9. Steegman-Olmedillas JL. The role of iron in tumour cell proliferation. Clin Transl Oncol 2011;13:71-76.
10. Onitilo AA, Engel JM, Sajjad SM. The possible role of hemochromatosis in testicular cancer. Med Hypotheses 2011;77:179-181 [Epub ahead of print].
11. Gannon PO, Medelci S, Le Page C, Beaulieu M, Provencher DM, Mes-Masson AM, Santos MM. Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis. Int J Cancer 2011;128:2326-2334.
12. Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, Fay WP. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 2003;107:2601-2606.
13. Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment. J Card Fail 2010;16:888-900.
14. Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J 2010;74:597-607.
15. Soslau G, Goldenberg SJ, Class R, Jameson B. Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta-, and gamma-thrombin. Platelets 2004;15:155-166.
16. Li Z, Delaney MK, O'Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010;30:2341-2349.
17. Azizova OA, Shvachko AG, Aseichev AV. Effect of iron ions on functional activity of thrombin. Bull Exp Biol Med 2009;148:776-779.
18. Basheer AR, El-Asmar MF, Soslau G. Characterization of a potent platelet aggregation inducer from Cerastes cerastes (Egyptian sand viper) venom. Biochim Biophys Acta 1995;1250:97-109.
19. Soslau G, Class R, Morgan DA, Foster C, Lord ST, Marchese P, Ruggeri ZM. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001;276:21173-21183.
20. Bianco C, Brittenham G, Gilcher RO, Gordeuk VR, Kushner JP, Sayers M, Chambers L, Counts RB, Aylesworth C, Nemo G, et al. Maintaining iron balance in women blood donors of childbearing age: Summary of a workshop. Transfusion 2002;42:798-805.
21. Kang JO. Chronic iron overload and toxicity: Clinical chemistry perspective. Clin Lab Sci 2001;14:209-219.
22. Eaton JW, Qian M. Molecular basis of cellular iron toxicity. Free Radic Biol Med 2002;32:833-840.
23. Jansen NW, Roosendaal G, Hooiveld MMJ, Bijlsma JWJ, van Roon JAG, Theobald M, Lafeber FPJG. Interleukin-10 protects against blood-induced joint damage. Br J Haematol 2008;142:953-961.
24. Heiland GR, Aigner E, Dallos T, Sahinbgovic E, Krenn V, Thaler C, Weiss G, Distler JH, Datz C, Schett G, et al. Synovial immunopathology in haemochromatosis arthropathy. Ann Rheum Dis 2010;69:1214-1219.